6-K:外国发行人报告
6-K:外国发行人报告
6-K:外国发行人报告
20-F:2023财年年报
6-K:外国发行人报告
6-K:外国发行人报告(业绩相关)
NT 20-F:年报延迟披露公告
6-K:外国发行人报告
6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | SC 13G:超过5%持股股东披露文件-TAN MENG DONG(26.40%),8I HOLDINGS 2 PTE. LTD.(9.03%)
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告(业绩相关)
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 424B3:募资说明书
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | 6-K:外国发行人报告
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | EFFECT:其他
EUDA HEALTH HOLDINGS LIMITED C/WTS 24/09/2026 (TO PUR COM) | CORRESP:信函
暂无数据